Evaluation of Lipids, Drug Concentration, and Safety Parameters Following Cessation of Treatment With the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib in Patients With or at High Risk for Coronary Heart Disease

Autor: Gotto, Antonio M., Jr., Cannon, Christopher P., Li, Xiujiang Susie, Vaidya, Sanskruti, Kher, Uma, Brinton, Eliot A., Davidson, Michael, Moon, Jennifer E., Shah, Sukrut, Dansky, Hayes M., Mitchel, Yale, Barter, Philip
Zdroj: In The American Journal of Cardiology 1 January 2014 113(1):76-83
Databáze: ScienceDirect
Externí odkaz: